An observational, prospective, open label, multicenter study to evaluate the safety and effectiveness of pegfilgrastim as secondary prophylaxis to decrease the incidence of febrile neutropenia in Korean female patients with breast cancer.
Breast
; 72: 103585, 2023 Dec.
Article
en En
| MEDLINE
| ID: mdl-37802015
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Neoplasias de la Mama
/
Neutropenia Febril
Tipo de estudio:
Clinical_trials
/
Incidence_studies
/
Observational_studies
/
Risk_factors_studies
Límite:
Female
/
Humans
País/Región como asunto:
Asia
Idioma:
En
Año:
2023
Tipo del documento:
Article